Alliance Pharma plc Stock Rating Reaffirmed by FinnCap (APH)
Alliance Pharma plc (LON:APH)‘s stock had its “hold” rating restated by research analysts at FinnCap in a report released on Wednesday. They currently have a GBX 36.50 ($0.63) price target on the stock. FinnCap’s price target points to a potential upside of 8.96% from the stock’s previous close.
Separately, analysts at Numis Securities Ltd cut their price target on shares of Alliance Pharma plc from GBX 39 ($0.67) to GBX 37 ($0.63) in a research note on Wednesday, May 21st. They now have an “add” rating on the stock.
Shares of Alliance Pharma plc (LON:APH) traded up 0.75% during mid-day trading on Wednesday, hitting GBX 33.50. 245,839 shares of the company’s stock traded hands. Alliance Pharma plc has a 52 week low of GBX 30.00 and a 52 week high of GBX 36.25. The stock’s 50-day moving average is GBX 33.47 and its 200-day moving average is GBX 34.19.
Alliance Pharma plc is a speciality pharmaceutical company. The principal activity of the Company is the acquisition, marketing and distribution of pharmaceutical products.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.